AMC Bio

AMC Bio’s scalable platform technology enables commercialization of truncated, optimized microbial peptide drugs for more sustainable anticancer, antiviral, and antibiotic therapies. Key Takeaways • AMC Bio is developing novel microbial peptide therapeutics with programs at early and late preclinical stages. • Just as antibiotic discovery from soil microbes revolutionized treatment of bacterial infections in the 20th Century, microbial peptides offer safer and more effective therapeutics for the 21st Century. • AMC Bio’s highly effective, non-toxic small-molecule therapeutics target solid cancer tumors, viral and bacterial infections.